A trial of long-acting Sulphonamide RO.4-4393 (Fanasil) in the treatment of Lepromatous Leprosy patients with repeated E.N.L. is reported in this paper. There were 9 patients treated with Fanasil in this trial for a period of 2 years. The results of the trial have shown that the treatment with Fanasil helps to prevent the occurrence of E.N.L. under treatment with D.D.S. In addition, even after the completion of treatment with Fanasil, these patients seem to be stabilised and are able to tolerate D.D.S. But, the clinical and Bacteriological progress under Fanasil therapy is not satisfactory.
BT - Leprosy in India C1 - http://www.ncbi.nlm.nih.gov/pubmed/1022953?dopt=Abstract CN - Infolep Library - available DA - 1976 Jan IS - 1 J2 - Lepr India LA - eng N2 -A trial of long-acting Sulphonamide RO.4-4393 (Fanasil) in the treatment of Lepromatous Leprosy patients with repeated E.N.L. is reported in this paper. There were 9 patients treated with Fanasil in this trial for a period of 2 years. The results of the trial have shown that the treatment with Fanasil helps to prevent the occurrence of E.N.L. under treatment with D.D.S. In addition, even after the completion of treatment with Fanasil, these patients seem to be stabilised and are able to tolerate D.D.S. But, the clinical and Bacteriological progress under Fanasil therapy is not satisfactory.
PY - 1976 SP - 24 EP - 30 T2 - Leprosy in India TI - A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L. VL - 48 SN - 0024-1024 ER -